Bimatoprost(Lumigan),
(5E)-Bimatoprost,
155206-00-1,
1163135-95-2,
AC1O6R5K,
BIDD:GT0386,
SCHEMBL10071021,
CHEBI:140470,
(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide,
ZINC3994921,
AKOS015964787,
AC-6101,
BC218955,
J-502618,
(Z)-7-((1R,2R)-3,5-dihydroxy-2-((E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide,
Bimatoprost,
Latisse,
Lumigan,
5,6-trans-Bimatoprost,
5,6-Trans Bimatoprost,
UNII-QXS94885MZ,
Bimatoprost [USAN:INN:BAN],
Bimatoprost [USAN:INN:BAN:JAN],
C25-H37-N-O4,
AGN 192024,
CID6505201,
CS-O-07369,
(5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprosta-5,13-dienoic acid ethylamide,